The effect of a long-acting glucagon preparation on endocrine and metabolic responses in acute myocardial infarction.
D000208:Acute Disease; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001799:Blood Sedimentation; D002395:Catecholamines / Q000652:urine; D003692:Delayed-Action Preparations; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use*; D013006:Growth Hormone / Q000097:blood; D006334:Heart Function Tests; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011479:Protamines / Q000494:pharmacology / Q000627:therapeutic use*; D015032:Zinc / Q000494:pharmacology / Q000627:therapeutic use*
D001786:Blood Glucose; D002395:Catecholamines; D003692:Delayed-Action Preparations; D007328:Insulin; D011479:Protamines; D013006:Growth Hormone; D005934:Glucagon; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D015032:Zinc